BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakagaki T, Nishida N, Satoh K. Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies. Front Aging Neurosci 2021;13:703984. [PMID: 34650422 DOI: 10.3389/fnagi.2021.703984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Cai H, Zhao J, Yu Z, Feng T. Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy. Front Aging Neurosci 2022;14:1010064. [DOI: 10.3389/fnagi.2022.1010064] [Reference Citation Analysis]
2 Tönges L, Buhmann C, Klebe S, Klucken J, Kwon EH, Müller T, Pedrosa DJ, Schröter N, Riederer P, Lingor P. Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice. J Neural Transm. [DOI: 10.1007/s00702-022-02498-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tönges L, Kwon EH, Klebe S. Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers. Front Aging Neurosci 2022;14:822949. [DOI: 10.3389/fnagi.2022.822949] [Reference Citation Analysis]
4 Srivastava A, Kataria A, Yadav DK, Han I, Choi E. Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease. Human-Gut Microbiome 2022. [DOI: 10.1016/b978-0-323-91313-3.00003-9] [Reference Citation Analysis]